Welcome to LookChem.com Sign In|Join Free

CAS

  • or

117704-25-3

Post Buying Request

117704-25-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

117704-25-3 Usage

Pig antiparasitic

Doramectin is a new generation of antiparasitic , compared with other commercially available ivermectin products, anti-parasite range of Doramectin is broader, with better effect, and Doramectin can prevent parasite reinfection for a longer valid time, It is the world's best, the most potential anti-parasitic drugs for development veterinary . Doramectin as a pesticide can kill all the the internal and external parasites , and is also valid to nematodes, arthropods. At present, Chinese pig industry commonly used insecticide drugs include: parasite drugs: albendazole, levamisole, trichlorfon, Vietnam, hygromycin, ivermectin, avermectin. External parasite drugs: trichlorfon, amitraz, diazinon, permethrin drugs, avermectin, ivermectin. Doramectin has a good effect on pig gastrointestinal nematodes , it is reported that pig is injected 0.3 mg/kg by intramuscular, dosing artificial and natural infection cases after 7 days , 14 days, 21 days, weight gains is significantly higher (swine P <0.0001); compared with the control group, percentage of getting rid of worms is 100%, and there are no side effects. In Pig scabies mite treatment, from piglets to sows ,Doramectin has good results .After artificial infection scabies mites, according to the body weight ,administrated 0.3 mg/kg intramuscularly, four weeks after the test, the result of inflammation of the skin injury in pigs and worms Elimination of infected body, is very significant (P <0.05). Treatment for pregnant sows kidney worm, press the 0.3 mg/kg dose neck single injection, the 56 day and 57 day of testing, the detection rate of Urine eggs is 0, the percentage of getting rid of them is 100%, while the control group per milliliter of urine displays 3762 eggs. For lung worms, lice and other pigs parasites,it has the same effect. According to more than l ng/g tissue concentration of the drug having anti-parasitic activity, the drug can be used to assess the validity. Duration time of Ivermectin is greater than 1 ng/g concentration :18 days for the skin, the lungs 18 days, 18 days for gastrointestinal mucosa, gastric mucosa wrinkled 18 days. Duration time of Doramectin is greater than 1 ng/g concentration: 26 days for the skin, the lungs 38 days, 38 days for gastrointestinal mucosa, gastric mucosa wrinkled 38 days. Thus,duration time of more than 1 ng/g doramectin in the gastrointestinal mucosa, lung tissue is 38 days, 20 days more than ivermectin. So the effect of doramectin to drive and to kill the parasites is stronger than ivermectin, and it can be effective to prevent the parasite reinfection . The above information is edited by the lookchem of Tian Ye.

Pharmacological effects

[Chemical properties] brown powder , very low solubility in water. Doramectin is used for the treatment of livestock diseases such as nematodes and mites ectoparasitosis,it is fermented by recombinant avermitilis (Streptomyces avermitilis) new strain, and the main difference from ivermectin is that C25 is substituted by cyclohexyl. It is a new, broad-spectrum antiparasitic drug,and is efficient for gastrointestinal nematodes, lung nematodes, Euglena, lice, ticks, mites and wound maggots , also has a good effect on internal and external parasites especially certain nematodes (round worms) and arthropods , but invalid to tapeworms, flukes and protozoa . Its mechanism of action is to increase the release of the inhibitory neurotransmitter γ-aminobutyric acid (GABA) of the worm, thereby blocking the transmission of nerve signals, so that muscle cells lose their ability to contract, resulting in death of the parasites. the neurotransmitter of Peripheral nerves of mammals is acetylcholine,and will not be affected by Doramectin, doramectin cannot go through the blood-brain barrier easily , minimal damage to the central nervous system,safe to cattle. The main feature is that the plasma concentration and half-life are higher or twice than Ivermectin. The United States has approved to use as cattle, pigs and dedicated injection and cattle dedicated pour.

Precautions

1, doramectin is unstable and decomposes rapidly in the sunlight to be inactivated, its remnants of drugs are toxic to fish and aquatic organisms, so pay attention to water protection. 2, pour-on: bovine application, not rain within 6 hours. 3, use with caution in dogs. 4, the goods will be placed out of reach of children, the operator should not eat or smoking, wash hands after handling. 5, withdrawal period, 35 days of cattle, pigs 24 days.

Description

Doramectin is a novel avermectin with a cyclohexyl substituent on the previously inaccessible C-25 position of the molecule; the substitution was facilitated by mutational biosynthesis. The discovery of doramectin involved feeding carboxylic acids or their precursors to a fermentation of Streptomyces avermitilis that lacked branched-chain 2-oxo acid dehydrogenase activity, and then screening the resultant fermentation products for anthelmintic and ectoparasiticidal activity (89). Two dosage forms of doramectin have been developed for use as an endectocide on cattle, an injectable formulation for subcutaneous administration and a pouron formulation. An injectable formulation is also approved for use on pigs.

Chemical Properties

White Solid

Uses

Different sources of media describe the Uses of 117704-25-3 differently. You can refer to the following data:
1. antibacterial
2. Doramectin is a biosynthetic avermectin derived from a mutant strain of Streptomyces avermitilis, supplemented with a cyclohexylcaboxylic acid starting unit. Doramectin was developed as an anthelmintic for internal parasite control. The presence of the cyclohexyl group replacing the sec-butyl moiety affords greater hydrophobicity and longer biological half-life compared to avermectin. Like the other milbemycin/avermectins, it selectively binds to parasite glutamate-gated chloride ion channels and disrupts neurotransmission leading to paralysis and death of the parasite.
3. A mutational biosynthetic antiparasitic antibiotic.
4. Mutational biosynthetic antiparasitic antibiotic structurally related to the avermectins

Veterinary Drugs and Treatments

Doramectin injection is indicated for the treatment and control of the following endo- and ectoparasites in cattle: roundworms (adults and some fourth stage larvae)—Ostertagia ostertagi (including inhibited larvae), O. lyrata, Haemonchus placei, Trichostrongylus axei, T. colubriformis, T. longispicularis, Cooperia oncophora, C. pectinata, C. punctata, C. surnabada (syn. mcmasteri), Bunostomum phlebotomum, Strongyloides papillosus, Oesophagostomum radiatum, Trichuris spp.; lungworms (adults and fourth stage larvae)—Dictyocaulus viviparus; eyeworms (adults)—Thelazia spp.; grubs (parasitic stages)—Hypoderma bovis, H. lineatum; lice—Haematopinus eurysternus, Linognathus vituli, Solenopotes capillatus; and mange mites—Psoroptes bovis, Sarcoptes scabiei. In swine the injection is labeled for the treatment and control gastrointestinal roundworms (adults and 4th stage Ascaris suum, adults and 4th stage Oesophagostomum dentatum, Oesophagostomum quadrispinolatum adults, Strongyloides ransomi adults, and Hydrostrongylus rubidus adults), lungworms (Stephanurus dentatus adults), mange mites (adults and immature stages Sarcoptes scabeii var. suis), and sucking lice (adults and immature stages Haematopinus suis) The manufacturer states the doramectin protects cattle against infection or reinfection with Ostertagia ostertagi for up to 21 days. Doramectin topical (pour-on) is approved for use in cattle and has a similar spectrum of action against a variety of endo- and ectoparasites, including biting lice. Injectable doramectin has been used for treating a variety of nematode and arthropod parasites in companion animals, including generalized demodicosis in dogs and cats and spirocercosis in dogs.

Check Digit Verification of cas no

The CAS Registry Mumber 117704-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,7,0 and 4 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 117704-25:
(8*1)+(7*1)+(6*7)+(5*7)+(4*0)+(3*4)+(2*2)+(1*5)=113
113 % 10 = 3
So 117704-25-3 is a valid CAS Registry Number.
InChI:InChI=1/C50H74O14/c1-27-13-12-16-34-26-57-47-42(51)30(4)21-37(50(34,47)54)48(53)60-36-22-35(63-49(25-36)20-19-29(3)45(64-49)33-14-10-9-11-15-33)18-17-28(2)44(27)61-41-24-39(56-8)46(32(6)59-41)62-40-23-38(55-7)43(52)31(5)58-40/h12-13,16-17,19-21,27,29,31-33,35-47,51-52,54H,9-11,14-15,18,22-26H2,1-8H3/b13-12+,28-17+,34-16-/t27-,29-,31-,32-,35+,36-,37-,38-,39-,40-,41-,42+,43-,44?,45-,46?,47+,49+,50+/m0/s1

117704-25-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name doramectin

1.2 Other means of identification

Product number -
Other names Doromectin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:117704-25-3 SDS

117704-25-3Synthetic route

doramectin
117704-25-3

doramectin

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

C52H69F3O13

C52H69F3O13

Conditions
ConditionsYield
With triethylamine In acetonitrile for 2h; Ambient temperature;77%
doramectin
117704-25-3

doramectin

5-ketodoramectin

5-ketodoramectin

Conditions
ConditionsYield
With manganese(IV) oxide In diethyl ether for 18h; Ambient temperature;72.5%
With silica gel; pyridinium chlorochromate In dichloromethane at 20℃; for 4h;15%
doramectin
117704-25-3

doramectin

25-cyclohexyl-5-demethoxy-25-de(1-methylpropyl)-5-(hydroxyimino)avermectin A1a

25-cyclohexyl-5-demethoxy-25-de(1-methylpropyl)-5-(hydroxyimino)avermectin A1a

Conditions
ConditionsYield
Stage #1: doramectin With manganese(IV) oxide In diethyl ether at 25℃; for 18h; Oxidation;
Stage #2: With hydroxylamine hydrochloride In 1,4-dioxane; methanol; water at 50℃; for 2h; oximation;
58%
Multi-step reaction with 2 steps
1: pyridinium chlorochromate; silica gel / dichloromethane / 4 h / 20 °C
2: hydroxylamine hydrochloride / isopropyl alcohol; water / 5 h / 20 °C
View Scheme
doramectin
117704-25-3

doramectin

C43H62O11

C43H62O11

Conditions
ConditionsYield
With sulfuric acid In tetrahydrofuran at 20℃; for 16h;36%
With sulfuric acid In tetrahydrofuran; water at 40℃; for 16h;100 g
doramectin
117704-25-3

doramectin

(8,9-Z)-doramectin

(8,9-Z)-doramectin

Conditions
ConditionsYield
In cyclohexane for 0.75h; Irradiation;25.7%
doramectin
117704-25-3

doramectin

C52H77NO15

C52H77NO15

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1H-imidazole; dmap / dichloromethane / 4 h / 20 °C / Inert atmosphere
2: dmap / dichloromethane / 3 h / 20 °C / Inert atmosphere
3: dmap / dichloromethane / 6 h / 20 °C / Inert atmosphere
4: toluene-4-sulfonic acid / methanol / 1 h / 20 °C / Inert atmosphere
View Scheme
doramectin
117704-25-3

doramectin

C64H95NO15Si

C64H95NO15Si

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1H-imidazole; dmap / dichloromethane / 4 h / 20 °C / Inert atmosphere
2: dmap / dichloromethane / 5 h / 20 °C / Inert atmosphere
View Scheme
doramectin
117704-25-3

doramectin

C58H81NO15

C58H81NO15

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1H-imidazole; dmap / dichloromethane / 4 h / 20 °C / Inert atmosphere
2: dmap / dichloromethane / 5 h / 20 °C / Inert atmosphere
3: toluene-4-sulfonic acid / methanol / 1 h / 20 °C / Inert atmosphere
View Scheme
doramectin
117704-25-3

doramectin

C60H90N2O15Si

C60H90N2O15Si

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1H-imidazole; dmap / dichloromethane / 4 h / 20 °C / Inert atmosphere
2: dmap / dichloromethane / 3 h / 20 °C / Inert atmosphere
View Scheme
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

doramectin
117704-25-3

doramectin

C56H88O14Si

C56H88O14Si

Conditions
ConditionsYield
With 1H-imidazole; dmap In dichloromethane at 20℃; for 4h; Inert atmosphere;
doramectin
117704-25-3

doramectin

C43H61NO11

C43H61NO11

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridinium chlorochromate; silica gel / dichloromethane / 4 h / 20 °C
2: hydroxylamine hydrochloride / isopropyl alcohol; water / 5 h / 20 °C
3: sulfuric acid / tetrahydrofuran / 6 h / 20 °C
View Scheme
doramectin
117704-25-3

doramectin

C51H75NO14

C51H75NO14

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridinium chlorochromate; silica gel / dichloromethane / 4 h / 20 °C
2: isopropyl alcohol; water / 4 h / 20 °C
View Scheme
doramectin
117704-25-3

doramectin

C44H63NO11

C44H63NO11

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: pyridinium chlorochromate; silica gel / dichloromethane / 4 h / 20 °C
2: isopropyl alcohol; water / 4 h / 20 °C
3: sulfuric acid / tetrahydrofuran / 6 h / 20 °C
View Scheme
doramectin
117704-25-3

doramectin

C50H75NO13

C50H75NO13

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridinium chlorochromate; silica gel / dichloromethane / 4 h / 20 °C
2: sodium cyanoborohydride; ammonium acetate; acetic acid / methanol / 48 h / 20 °C
View Scheme
doramectin
117704-25-3

doramectin

C43H64O11

C43H64O11

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sulfuric acid / tetrahydrofuran; water / 16 h / 40 °C
2: Wilkinson's catalyst; hydrogen / toluene / 6 h / 35 °C / 3000.3 Torr
View Scheme
Multi-step reaction with 2 steps
1: Wilkinson's catalyst; hydrogen / acetone / 35 - 40 °C / 2250.23 - 3000.3 Torr / Large scale
2: sulfuric acid / isopropyl alcohol / 2.5 h / 20.2 - 24 °C / Autoclave; Inert atmosphere; Large scale
View Scheme
doramectin
117704-25-3

doramectin

C43H62O11

C43H62O11

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sulfuric acid / tetrahydrofuran; water / 16 h / 40 °C
2: Wilkinson's catalyst; hydrogen / toluene / 6 h / 35 °C / 3000.3 Torr
3: manganese(IV) oxide / acetone / 1 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: Wilkinson's catalyst; hydrogen / acetone / 35 - 40 °C / 2250.23 - 3000.3 Torr / Large scale
2: sulfuric acid / isopropyl alcohol / 2.5 h / 20.2 - 24 °C / Autoclave; Inert atmosphere; Large scale
3: manganese(IV) oxide / dichloromethane / 20 - 25 °C / Inert atmosphere; Autoclave; Large scale
View Scheme
doramectin
117704-25-3

doramectin

A

C50H72O14

C50H72O14

B

C50H74O14

C50H74O14

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Wilkinson's catalyst; hydrogen / toluene / 4 h / 40 °C / 3000.3 Torr / Autoclave
2: 1-hydroxy-3H-benz[d][1,2]iodoxole-1,3-dione; manganese(IV) oxide / dimethyl sulfoxide / 1.75 h / 25 - 30 °C
View Scheme

117704-25-3Upstream product

117704-25-3Relevant articles and documents

Process and antiparasitic intermediates for doramectin

-

, (2008/06/13)

Intermediates and a process for preparing doramectin, the compound of formula (I), semisynthetically from by-product in the fermentation procedure which also yields the compound of formula (I). The intermediates prepared by the process of this invention also have utility as antiparasitic agents. The process of this invention utilizes continuous reaction inert gas sparging during the pyrolysis step, resulting in a significant improvement in the overall yield of this conversion. STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 117704-25-3